Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Clinical Trials - The Bloodline with LLS
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. In this episode, Dr. Wang delves into the rare blood cancer, blastic plasmacytoid dendritic cell neoplasm (BPDCN). Usually identified by characteristic deep purple lesions, oncologists continue to raise awareness of this rare diagnosis, as swift referral and treatment usually leads to better outcomes. After being universally identified as BPDCN by World Health Organization (WHO) in 2018, clinical trials and CAR T-cell therapies have brought new hope to BPDCN patients.
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Why Roswell Park for Leukemia & Blood Cancers
- Stem Cell Transplantation
- CAR T-cell Therapy
- Clinical Trial Support Center
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Financial support
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
- LLS Advocacy
- LLS Myeloma Link
Support for this episode provided by ImmunoGen.
The post Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) first appeared on The Bloodline with Blood Cancer United Podcast.